Literature DB >> 29506849

Disparities in fertility-sparing surgery in adolescent and young women with stage I ovarian dysgerminoma.

Laura L Stafman1, Ilan I Maizlin1, Matthew Dellinger2, Kenneth W Gow2, Melanie Goldfarb3, Jed G Nuchtern4, Monica Langer5, Sanjeev A Vasudevan4, John J Doski6, Adam B Goldin2, Mehul Raval7, Elizabeth A Beierle8.   

Abstract

BACKGROUND: In many cancers, racial and socioeconomic disparities exist regarding the extent of surgery. For ovarian dysgerminoma, fertility-sparing (FS) surgery is recommended whenever possible. The aim of this study was to investigate rates of FS versus non-fertility-sparing (NFS) procedures for stage I ovarian dysgerminoma in adolescents and young adults (AYAs) by ethnicity/race and socioeconomic status.
MATERIALS AND METHODS: The National Cancer Data Base was queried for patients with ovarian dysgerminoma from 1998 to 2012. After selecting patients aged 15-39 y with stage I disease, a multivariate regression analysis was performed, and rates of FS and NFS procedures were compared, first according to ethnicity/race, and then by socioeconomic surrogate variables.
RESULTS: Among the 687 AYAs with stage I ovarian dysgerminoma, there was no significant difference in rates of FS and NFS procedures based on ethnicity/race alone (P = 0.17), but there was a significant difference in procedure type for all three socioeconomic surrogates. The uninsured had higher NFS rates (30%) than those with government (21%) or private (19%) insurance (P = 0.036). Those in the poorest ZIP codes had almost twice the rate of NFS procedures (31%) compared with those in the most affluent ZIP codes (17%). For those in the least-educated regions, 24% underwent NFS procedures compared to 14% in the most-educated areas (P = 0.027).
CONCLUSIONS: AYAs with stage I ovarian dysgerminoma in lower socioeconomic groups were more likely to undergo NFS procedures than those in higher socioeconomic groups, but there was no difference in rates of FS versus NFS procedures by ethnicity/race. Approaches aimed at reducing socioeconomic disparities require further examination.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Disparity; Dysgerminoma; Fertility; Race; Socioeconomic; Surgery

Mesh:

Year:  2017        PMID: 29506849      PMCID: PMC5844365          DOI: 10.1016/j.jss.2017.11.046

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  33 in total

1.  Racial disparities and patterns of ovarian cancer surgical care in California.

Authors:  F W Liu; L M Randall; K S Tewari; R E Bristow
Journal:  Gynecol Oncol       Date:  2013-09-07       Impact factor: 5.482

2.  Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).

Authors:  O Solheim; D M Gershenson; C G Tropé; E Rokkones; C C Sun; H Weedon-Fekjaer; S D Fosså
Journal:  Eur J Cancer       Date:  2014-05-20       Impact factor: 9.162

3.  Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  N Colombo; M Peiretti; A Garbi; S Carinelli; C Marini; C Sessa
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

4.  Incidence and survival rates for female malignant germ cell tumors.

Authors:  Harriet O Smith; Marianne Berwick; Claire F Verschraegen; Charles Wiggins; Letitia Lansing; Carolyn Y Muller; Clifford R Qualls
Journal:  Obstet Gynecol       Date:  2006-05       Impact factor: 7.661

5.  The incidences of malignant gonadal and extragonadal germ cell tumors in males and females: a population-based study covering over 40 years in Finland.

Authors:  Satu-Liisa Pauniaho; Jonna Salonen; Mika Helminen; Kim Vettenranta; Markku Heikinheimo; Oskari Heikinheimo
Journal:  Cancer Causes Control       Date:  2012-09-26       Impact factor: 2.506

6.  Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.

Authors:  Deborah Schrag; Craig Earle; Feng Xu; Katherine S Panageas; K Robin Yabroff; Robert E Bristow; Edward L Trimble; Joan L Warren
Journal:  J Natl Cancer Inst       Date:  2006-02-01       Impact factor: 13.506

7.  Fertility and ovarian function after conservative surgery for germ cell tumours of the ovary.

Authors:  L C Perrin; J Low; J L Nicklin; B G Ward; A J Crandon
Journal:  Aust N Z J Obstet Gynaecol       Date:  1999-05       Impact factor: 2.100

8.  Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Registry.

Authors:  A Gordon; D Lipton; J D Woodruff
Journal:  Obstet Gynecol       Date:  1981-10       Impact factor: 7.661

Review 9.  Current therapy for dysgerminoma of the ovary.

Authors:  G M Thomas; A J Dembo; N F Hacker; A D DePetrillo
Journal:  Obstet Gynecol       Date:  1987-08       Impact factor: 7.661

Review 10.  Psychological aspects of fertility preservation in men and women affected by cancer and other life-threatening diseases.

Authors:  Sibil Tschudin; Johannes Bitzer
Journal:  Hum Reprod Update       Date:  2009-05-10       Impact factor: 15.610

View more
  1 in total

Review 1.  Fertility-Sparing Treatment for Early-Stage Cervical, Ovarian, and Endometrial Malignancies.

Authors:  Roni Nitecki; Terri Woodard; J Alejandro Rauh-Hain
Journal:  Obstet Gynecol       Date:  2020-12       Impact factor: 7.623

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.